Breast cancer drug shows better results
95999
A newer drug clearly outperforms tamoxifen at preventing breast cancer from returning and should become the first-choice treatment for most women who have had the disease, doctors are reporting.
668672
MONDAY, Feb. 26 (HealthDay News) -- Breast cancer treatment trials that are funded by drug companies are more likely to show positive results than studies sponsored by other sources, new research suggests.
415904
LONDON - Arimidex, one of a new class of breast cancer drugs, has clearly beaten standard treatment tamoxifen at preventing breast cancer from returning in a 5-year study, researchers said on Wednesday.
21073
Thousands of women diagnosed with breast cancer should be given a new drug instead of the standard treatment because it is safer, more effective and may increase overall survival rates, doctors said yesterday.
506148
It's running trials to see if the drug can be used in earlier stages of cancer.
638713
A new type of cancer drug being  developed by Bristol-Myers Squibb Co., when combined with a  standard chemotherapy, was significantly better than  chemotherapy alone in delaying progression of advanced breast  cancer, a researcher said on Sunday.
163988
SAN ANTONIO Dec 8, 2004 - A newer drug clearly outperforms tamoxifen at preventing breast cancer from returning and should become the first-choice treatment for most women who have had the disease, doctors are reporting.
195956
A newer drug prevented far more breast cancers from recurring in older women than the old standby tamoxifen and with far fewer side effects, doctors said Wednesday, citing a new study.
728865
Novartis AG said on Wednesday that its  breast cancer pill Femara is more effective than the current  standard treatment tamoxifen in reducing the risk that the  cancer will return to older women after surgery.
320785
The results of studies released today show a new blood test holds promise for improving the treatment of advanced breast cancer.
243349
This lung cancer drug is not as effective as once hoped.
97798
Dec. 8, 2004 (San Antonio) -- Postmenopausal women with breast cancer fare better if they are treated with a new class of hormone drugs called aromatase inhibitors than if they are given tamoxifen, the standard
458471
12/8/04- the drug tamoxifen has long been the 1st line of therapy for preventing the return of breast cancer, but researchers say another drug may be more effective and could soon become the 1st choice treatment for post-menopausal women who&#39;ve had the
579884
A new technology that counts cancer cells in the blood helps predict the success of breast cancer treatments more quickly and more reliably than established methods, researchers reported.
450946
A new technology that counts cancer cells in the blood helps predict the success of breast cancer treatments more quickly and more reliably than established methods, researchers reported Wednesday.
53226
THE REPORT: Doctors are reporting that a new breast cancer drug, Arimidex, and others in its class outperform the tried-and-true tamoxifen at preventing recurrence in older women.
262303
The results of the five-year trial involving 9,300 women, the largest ever on breast cancer, show that women taking the aromatase inhibitor anastrozole (brand name Arimidex) were less likely to have their cancer spread.